Key facts
- Sentire Medical Systems’s last known valuation is $2.6M (Jan 2018).
- It has raised $1.8M across 2 recorded rounds; the latest was Seed Round ($1.2M) in Dec 2025.
- Notable investors include US National Science Foundation, ShangBay Capital, Peachscore, New Mexico Economic Development Department, New Mexico LEEP.
- Sentire Medical Systems has filed 1 Form D with the SEC, most recently Jan 2018 ($600K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Sentire Medical Systems
Funding rounds
2 roundsAbout Sentire Medical Systems
Developer of an intraoperative monitoring system designed to detect bowel perforations in real time during minimally invasive surgical procedures. The company offers a patented monitoring device that alerts surgeons to the presence of bowel gas during laparoscopic and robotic surgeries, enabling surgeons performing abdominal procedures to identify perforations promptly and reduce complications associated with delayed treatment.
- Sector
- Healthcare
- HQ
- North Palm Beach, FL, United States
- Founded
- 2011
- Employees
- 6
- Website
- sentiremedical.com/
- Ownership
- Privately Held (backing)
Sentire Medical Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sentire Medical Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sentire Medical Systems in its N-PORT filings yet. We sweep new filings monthly.